Atlas Trials

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Clinical trial NCT06193863 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06193863
Sponsor
Bayer
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Prevention of Venous ThromboembolismCongenital Heart DiseaseFontan ProcedureChildren
Start date
2024-06-18
Primary completion
2026-06-30
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.